Login to Your Account



Astrazeneca sells historic R&D home

By Nuala Moran
Staff Writer

Thursday, March 13, 2014

ALDERLEY PARK, CHESHIRE – Astrazeneca plc has sold its historic research and development home at Alderley Park, Cheshire, for development as a bioincubator and science park, as it advances the plan to bring small molecules and biologics R&D carried out by the Medimmune Inc. subsidiary together at a new $500 million global research center it is building in Cambridge.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription